<DOC>
	<DOCNO>NCT01795872</DOCNO>
	<brief_summary>This study assess clinical image long-term data , early delay interferon-beta-1b treatment patient first demyelinate event suggestive multiple sclerosis ( MS ) , 11 year enrollment Betaferon/Betaseron Newly Emerging Multiple Sclerosis Initial Treatment ( BENEFIT ) study ( 304747 ) . The main objective describe disease course , change disability , cognitive function , resource use employment status , relation Interferon beta-1b long term .</brief_summary>
	<brief_title>Follow-up Study After 11 Years Patients Who Were Included BENEFIT Trial ( 304747 ) With First Demyelinating Event Suggestive Multiple Sclerosis</brief_title>
	<detailed_description>As optic coherence tomography ( OCT ) magnetic resonance imaging ( MRI ) study essential standardize procedure assessment OCT MRI test center may take part study , 122 additional volunteer enrol test dummy scan OCT MRI , .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Male female patient clinicalisolated syndrome multiple sclerosis treat least BENEFIT Study 304747 Patients , accord investigator 's judgment , medical , psychiatric , condition compromise patient 's ability understand purpose study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>